(Q34354401)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23812802%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

meta-analysis

0 references

title

Efficacy and tolerability of perospirone in schizophrenia: a systematic review and meta-analysis of randomized controlled trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23812802%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23812802%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Taro Kishi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23812802%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

publication date

1 September 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23812802%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23812802%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23812802%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23812802%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

731-741

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23812802%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0085-7

Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0085-7

Blonanserin for schizophrenia: systematic review and meta-analysis of double-blind, randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0085-7

A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0085-7

Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0085-7

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0085-7

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0085-7

Extrapyramidal symptom profiles in Japanese patients with schizophrenia treated with olanzapine or haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0085-7

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0085-7

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0085-7

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0085-7

A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0085-7

Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0085-7

Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0085-7

How meta-analysis increases statistical power

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23812802

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effects of changing from typical to atypical antipsychotic drugs on subjective sleep quality in patients with schizophrenia in a Japanese population.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23812802

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Current topics in neuroleptic-induced extrapyramidal symptoms in Japan.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23812802

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S40263-013-0085-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23812802%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference